• Intellia Therapeutics, Inc. (NASDAQ:NTLA) Given Average Recommendation of "Moderate Buy" by Analysts

    Source: Buzz FX / 24 Feb 2025 03:13:19   America/New_York


    Intellia Therapeutics, Inc. (NASDAQ:NTLA) Given Average Recommendation of "Moderate Buy" by Analysts Written by MarketBeat February 24, 2025 Share Link copied to clipboard. Shares of Intellia Therapeutics, Inc.
    Read more...
Share on,